JANUS HENDERSON GROUP PLC OWNS 10.1% OF SOLENO THERAPEUTICS, INC.

Company

JANUS HENDERSON GROUP PLC

Filed

October 3, 2024

Accession Number

0001274173-24-000080

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →